Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection

Summary

This is prospective double-blind study in the United States is designed to investigate the efficacy and safety of a single dose of COVI-DROPS or matched placebo in outpatient adults with mild symptoms associated with COVID-19 and a recent positive COVID-19 test.

Timeline

Start

2021-11

Primary completion

2022-11

Completion

2023-01

Outcome

Outcome not reported

Stopped: “to be replaced with a different protocol”

Drugs

Indications